NanoRepro AG (NN6) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.055x

Based on the latest financial reports, NanoRepro AG (NN6) has a cash flow conversion efficiency ratio of 0.055x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.05 Million ≈ $2.40 Million USD) by net assets (€37.30 Million ≈ $43.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NanoRepro AG stock valuation for the company's overall valuation and market capitalisation.

NanoRepro AG - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how NanoRepro AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NanoRepro AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NanoRepro AG ranked by their cash flow conversion efficiency. Explore NN6 cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Key Tronic Corporation
NASDAQ:KTCC
-0.039x
Vietnam Petroleum Transport JSC
VN:VIP
-0.030x
Interhides Public Company Limited
BK:IHL
0.018x
Agroton Public Ltd.
WAR:AGT
-0.142x
Geomega Resources Inc
V:GMA
-0.797x
GEE Group Inc
NYSE MKT:JOB
-0.024x
A SPAC III Acquisition Corp. Class A Ordinary Shares
NASDAQ:ASPC
-0.056x
Seoyon Topmetal Co. Ltd
KQ:019770
0.081x

Annual Cash Flow Conversion Efficiency for NanoRepro AG (2013–2024)

The table below shows the annual cash flow conversion efficiency of NanoRepro AG from 2013 to 2024. View NanoRepro AG (NN6) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €38.14 Million
≈ $44.59 Million
€9.86 Million
≈ $11.53 Million
0.259x +201.70%
2023-12-31 €40.38 Million
≈ $47.20 Million
€-10.26 Million
≈ $-12.00 Million
-0.254x -191.73%
2022-12-31 €47.43 Million
≈ $55.45 Million
€13.14 Million
≈ $15.37 Million
0.277x +95.60%
2021-12-31 €57.61 Million
≈ $67.35 Million
€8.16 Million
≈ $9.54 Million
0.142x +200.82%
2020-12-31 €7.99 Million
≈ $9.34 Million
€-1.12 Million
≈ $-1.31 Million
-0.141x -1.63%
2019-12-31 €4.43 Million
≈ $5.18 Million
€-612.40K
≈ $-715.96K
-0.138x -201.53%
2018-12-31 €5.62 Million
≈ $6.57 Million
€-257.60K
≈ $-301.16K
-0.046x +84.68%
2017-12-31 €3.82 Million
≈ $4.47 Million
€-1.14 Million
≈ $-1.34 Million
-0.299x -18.04%
2016-12-31 €3.03 Million
≈ $3.55 Million
€-769.70K
≈ $-899.86K
-0.254x +38.28%
2015-12-31 €2.27 Million
≈ $2.66 Million
€-934.60K
≈ $-1.09 Million
-0.411x -43.01%
2014-12-31 €1.91 Million
≈ $2.23 Million
€-548.00K
≈ $-640.67K
-0.287x +39.65%
2013-12-31 €1.64 Million
≈ $1.92 Million
€-783.00K
≈ $-915.41K
-0.476x --

About NanoRepro AG

XETRA:NN6 Germany Diagnostics & Research
Market Cap
$25.29 Million
€21.63 Million EUR
Market Cap Rank
#24435 Global
#2103 in Germany
Share Price
€1.72
Change (1 day)
+0.88%
52-Week Range
€1.38 - €2.29
All Time High
€17.14
About

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preve… Read more